Trial · NCT01986933
Participant flow45
How many started, completed or left each group, period by period.
21 to 40 of 45
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Active-to-active (Part B) | COMPLETED | Placebo | 0 | |
| Active-to-active (Part B) | COMPLETED | Nemoliozumab (0.1 mg/kg) Q4W | 31 | |
| Active-to-active (Part B) | COMPLETED | Nemoliozumab (0.5 mg/kg) Q4W | 28 | |
| Active-to-active (Part B) | COMPLETED | Nemoliozumab (2.0 mg/kg) Q4W | 30 | |
| Active-to-active (Part B) | COMPLETED | Nemoliozumab (2.0 mg/kg) Q8W | 19 | |
| Active-to-active (Part B) | NOT COMPLETED | Placebo | 0 | |
| Active-to-active (Part B) | NOT COMPLETED | Nemoliozumab (0.1 mg/kg) Q4W | 10 | |
| Active-to-active (Part B) | NOT COMPLETED | Nemoliozumab (0.5 mg/kg) Q4W | 10 | |
| Active-to-active (Part B) | NOT COMPLETED | Nemoliozumab (2.0 mg/kg) Q4W | 9 | |
| Active-to-active (Part B) | NOT COMPLETED | Nemoliozumab (2.0 mg/kg) Q8W | 16 | |
| Placebo-to-active (Part B) | STARTED | Placebo | 0 | |
| Placebo-to-active (Part B) | STARTED | Nemoliozumab (0.1 mg/kg) Q4W | 13 | |
| Placebo-to-active (Part B) | STARTED | Nemoliozumab (0.5 mg/kg) Q4W | 12 | |
| Placebo-to-active (Part B) | STARTED | Nemoliozumab (2.0 mg/kg) Q4W | 13 | |
| Placebo-to-active (Part B) | STARTED | Nemoliozumab (2.0 mg/kg) Q8W | 0 | |
| Placebo-to-active (Part B) | COMPLETED | Placebo | 0 | |
| Placebo-to-active (Part B) | COMPLETED | Nemoliozumab (0.1 mg/kg) Q4W | 8 | |
| Placebo-to-active (Part B) | COMPLETED | Nemoliozumab (0.5 mg/kg) Q4W | 7 | |
| Placebo-to-active (Part B) | COMPLETED | Nemoliozumab (2.0 mg/kg) Q4W | 8 | |
| Placebo-to-active (Part B) | COMPLETED | Nemoliozumab (2.0 mg/kg) Q8W | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01986933/flow?page=2